Predictors of clinically significant prostate cancer in biopsy-naïve and prior negative biopsy men with a negative prostate MRI: improving MRI-based screening with a novel risk calculator

PURPOSE: A pre-biopsy decision aid is needed to counsel men with a clinical suspicion for clinically significant prostate cancer (csPCa), despite normal prostate magnetic resonance imaging (MRI). METHODS: A risk calculator (RC) for csPCa (International Society of Urological Pathology grade group (IS...

Descripción completa

Detalles Bibliográficos
Autores principales: van Riel, Luigi A.M.J.G., Jager, Auke, Meijer, Dennie, Postema, Arnoud W., Smit, Ruth S., Vis, André N., de Reijke, Theo M., Beerlage, Harrie P., Oddens, Jorg R.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2022
Materias:
Current Best Practice for Prostate Biopsy: What is the evidence?
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8958520/
https://www.ncbi.nlm.nih.gov/pubmed/35356754
http://dx.doi.org/10.1177/17562872221088536

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8958520/
https://www.ncbi.nlm.nih.gov/pubmed/35356754
http://dx.doi.org/10.1177/17562872221088536

Ejemplares similares